Sofosbuvir 400 mg
Sofosbuvir 400 mg Tablets are a nucleotide analogue antiviral agent that inhibit hepatitis C virus replication and form a key component of modern, interferon-free treatment regimens for chronic hepatitis C infection, in line with globally recognized therapeutic recommendations.
Product Details
Therapeutic Class
Direct-Acting Antiviral (DAA)
NS5B Polymerase Inhibitor
Indication
Treatment of chronic hepatitis C virus (HCV) infection in adults, as part of combination antiviral therapy, in accordance with WHO-recommended treatment guidelines.
Dosage & Administration
400 mg once daily, in combination with other antiviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a guideline-recommended HCV treatment regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
28 tablets
Sofosbuvir 400 mg
Sofosbuvir 400 mg Tablets are a nucleotide analogue antiviral agent that inhibit hepatitis C virus replication and form a key component of modern, interferon-free treatment regimens for chronic hepatitis C infection, in line with globally recognized therapeutic recommendations.
Product Details
Therapeutic Class
Direct-Acting Antiviral (DAA)
NS5B Polymerase Inhibitor
Indication
Treatment of chronic hepatitis C virus (HCV) infection in adults, as part of combination antiviral therapy, in accordance with WHO-recommended treatment guidelines.
Dosage & Administration
400 mg once daily, in combination with other antiviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a guideline-recommended HCV treatment regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
28 tablets
Sofosbuvir 400 mg
Sofosbuvir 400 mg Tablets are a nucleotide analogue antiviral agent that inhibit hepatitis C virus replication and form a key component of modern, interferon-free treatment regimens for chronic hepatitis C infection, in line with globally recognized therapeutic recommendations.
Product Details
Therapeutic Class
Direct-Acting Antiviral (DAA)
NS5B Polymerase Inhibitor
Indication
Treatment of chronic hepatitis C virus (HCV) infection in adults, as part of combination antiviral therapy, in accordance with WHO-recommended treatment guidelines.
Dosage & Administration
400 mg once daily, in combination with other antiviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a guideline-recommended HCV treatment regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
28 tablets